Q&A: Diabetic Retinopathy Screening Devices and Technologies
Wade Brosius, DO, Shelton Hager, MD, and Steven Peskin, MD, answer questions relating to diabetic retinopathy screening devices and highlight novel technologies utilized in this space.
Q&A: Diabetic Retinopathy Screening Importance and Practice Pearls
A panel of experts in the management of diabetes answer questions relating to the importance of early screening and detection of diabetic retinopathy and provide practice pearls for how to facilitate in-office screenings.
Case 2: Prevention of Diabetic Retinopathy in a Patient with Type 2 Diabetes
Allen Dobson, Jr., MD, FAAFP, reviews the case of a 49-year-old woman with type 2 diabetes and the panel comments on their approaches to continued care and disease prevention.
Diabetic Retinopathy Screening Cost of Care and Practice Value
Wade Brosius, DO, and Steven Peskin, MD, review the cost of care and reimbursement schemes available to practitioners completing diabetic retinopathy screenings.
Recognizing and Addressing Barriers to Diabetic Retinopathy Screening
Key opinion leaders in diabetes management provide insight on recognizing and addressing barriers to care and screening for diabetic retinopathy.
Case 1: New Patient Screening and Initial Diagnosis of Diabetic Retinopathy
Allen Dobson, Jr., MD, FAAFP, reviews the case of a 67-year-old man with type 2 diabetes and the panel discusses initial diagnosis and management.
Diabetic Retinopathy Screening Guidelines and the Role of the Ophthalmologist
Key opinion leaders in diabetes management comment on the practical considerations of screening in clinical practices and note the importance of creating a replicable workflow for busy practices.
Practical Considerations in Diabetic Retinopathy Screening
An expert in the management of diabetes provides insight into common challenges leading to low rates of diabetic retinopathy screening in primary care settings, highlighting the need to increase access to care.
Clinical and Economic Burden of Diabetic Retinopathy
Wade Brosius, DO, and Steven Peskin, MD, discuss the clinical and economic burden of diabetic retinopathy, highlighting the impact on patients’ quality of life and the health care system.
Diabetic Retinopathy: Overview and Pathogenesis
Allen Dobson, Jr., MD, FAAFP; Wade Brosius, DO; and Shelton Hager, MD, provide an overview of diabetic retinopathy and discuss risk factors leading to its pathogenesis.
2 Clarke Drive Cranbury, NJ 08512